CustoScan | CAR-T Detection, GMP Reagents, Gene Editing sgRNA
Trusted by top research institutes, biopharma companies, and clinical labs worldwide
Trusted by top research institutes, biopharma companies, and clinical labs worldwide
Our CAR-T detection antibodies are developed by BioSwan Laboratories, offering industry-leading sensitivity with a detection limit of 0.001% (1 CAR-T cell in 100,000 PBMCs). These antibodies enable accurate flow cytometry monitoring of CAR-T expansion, persistence, and treatment efficacy during clinical trials and patient follow-up.
BioSwan's detection reagents are trusted by prestigious institutions such as Harvard University and Baylor Institute for advanced CAR-T cell monitoring and research.
Our comprehensive range of GMP-grade cell therapy reagents is supplied by T&L Biotechnology. The portfolio includes recombinant cytokines (IL-7, IL-15, IL-21, GM-CSF, FLT3-L), ActSep® and NanoSep™ magnetic beads for cell isolation and activation, and chemically defined media for clinical-grade T cell, NK cell, and stem cell production.
Manufactured under ISO9001, ISO13485, and GMP-compliant conditions, T&L Biotechnology's reagents support safe, consistent, and scalable production processes in cell and gene therapy applications, with DMF support available.
Explore Reagents
Our synthetic sgRNA products are developed by Pixel Biosciences, utilizing proprietary nMECA enzymatic synthesis technology to achieve ultra-high purity and minimal immunogenicity. Produced in a GMP-certified facility, these sgRNAs are ideal for CRISPR-Cas9 gene editing, gene knockout studies, and therapeutic gene modification projects.
Pixel Biosciences offers sgRNAs ranging from 17 to 170+ nucleotides, enabling precision genome editing with enhanced stability and efficiency in sensitive primary cells and therapeutic models.
Explore sgRNA